Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor Positive, HER2 Negative Patients Likely to Benefit From Neoadjuvant Chemotherapy

BACKGROUND: The benefit of neoadjuvant therapy (NAC) in patients with estrogen receptor positive (ER+) HER2− breast cancers and in invasive lobular cancer (ILC) is uncertain due to low rates of pathologic complete response (pCR). Our aim was to determine if pathologic features can identify subsets l...

全面介紹

Na minha lista:
書目詳細資料
發表在:Ann Surg Oncol
Main Authors: Petruolo, Oriana A., Pilewskie, Melissa, Patil, Sujata, Barrio, Andrea V., Stempel, Michelle, Wen, Hannah Y., Morrow, Monica
格式: Artigo
語言:Inglês
出版: 2017
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5649343/
https://ncbi.nlm.nih.gov/pubmed/28560596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-017-5898-z
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍